EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systemic Protein Biomarkers, Composite Blood Inflammatory Indices and Cellular Ratios in Metastatic Colorectal Cancer: Potential Therapeutic Targets

Teresa Smit, Ronald Anderson, Helen C Steel iD, Theresa M Rossouw iD, Bernardo L Rapoport

Diseases · 27.04.2026 · 14 (5) · 153

DOI: 10.3390/diseases14050153 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diseases, online erschienen am 27.04.2026. Verfasst von Teresa Smit und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Clinical and Translational Research Unit (CTRU) of the Medical Oncology Centre of Rosebank, Saxonwold, Johannesburg 2196, South Africa. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche (South Africa), The Medical Oncology Centre of Rosebank, University of Pretoria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/objectives: Although informative, current insights into the inflammatory nature of colorectal cancer (CRC) have yet to have a meaningful impact on the prevention of, and development of novel therapies for, the treatment of this prevalent and challenging disease. Accordingly, the current study was focused on identifying putative, key, systemic, mostly pro-inflammatory biomarkers of metastatic CRC (mCRC) prognosis and outcome.

Methods

Patients with mCRC (n = 38) and matched healthy controls (n = 30) were recruited to the study. A multiplex magnetic bead array system and an ELISA procedure were used to measure the plasma concentrations of selected cytokines (n = 25) and that of C-reactive protein (CRP) by immunonephelometry. Systemic inflammatory indices (n = 5) were derived from the hematological data.

Results

Plasma levels of 17/25 of the cytokine biomarkers and CRP were found to be significantly elevated, while the neutrophil/lymphocyte ratio proved to be the most useful of the various inflammatory indices. Subgroup analysis of the data derived from the group of mCRC patients revealed that the intensity of the systemic inflammatory response was mostly unaffected by tumor location, age, gender, and treatment line. The exception was time to progression, with a shorter time (

Schlagwörter

Stichwörter der Autor:innen

C-reactive protein (CRP)hierarchical cluster analysisinflammationinterleukin-13 (IL-13)interleukin-1β (IL-1β)interleukin-6 (IL-6)metastatic colorectal cancerneutrophil/lymphocyte ratio (NLR)therapeutic monoclonal antibody targetingtransforming growth factor-β1 (TGF-β1)

Autor:innen und Institutionen

  • The Clinical and Translational Research Unit (CTRU) of the Medical Oncology Centre of Rosebank, Saxonwold, Johannesburg 2196, South Africa.
  • Department of Immunology, Faculty of Health Sciences, University of Pretoria, Prinshof, Pretoria 0083, South Africa.
  • Centre for Innovative Immunology Research and Education (IINSPIRE), Department of Paediatrics and Child Health, Faculty of Health Sciences, University of Pretoria, Prinshof, Pretoria 0083, South Africa.

ORCID-Profile: Helen C Steel, Theresa M Rossouw

Förderung

  • Roche (South Africa)
  • The Medical Oncology Centre of Rosebank
  • University of Pretoria

Zitieren

APA

Smit, T., Anderson, R., Steel, H. C., Rossouw, T. M., & Rapoport, B. L. (2026). Systemic Protein Biomarkers, Composite Blood Inflammatory Indices and Cellular Ratios in Metastatic Colorectal Cancer: Potential Therapeutic Targets. Diseases, 14(5), 153. https://doi.org/10.3390/diseases14050153

Vancouver

Smit T, Anderson R, Steel HC, Rossouw TM, Rapoport BL. Systemic Protein Biomarkers, Composite Blood Inflammatory Indices and Cellular Ratios in Metastatic Colorectal Cancer: Potential Therapeutic Targets. Diseases. 2026;14(5):153. doi:10.3390/diseases14050153

BibTeX
@article{Smit2026,
  author = {Smit, Teresa and Anderson, Ronald and Steel, Helen C and Rossouw, Theresa M and Rapoport, Bernardo L},
  title = {Systemic Protein Biomarkers, Composite Blood Inflammatory Indices and Cellular Ratios in Metastatic Colorectal Cancer: Potential Therapeutic Targets},
  journal = {Diseases},
  year = {2026},
  volume = {14},
  number = {5},
  pages = {153},
  doi = {10.3390/diseases14050153}
}
Kostenlos starten →